Additive insulinotropic effects of exogenous synthetic human gastric inhibitory polypeptide and glucagon-like peptide-1-(7–36) amide infused at near-physiological insulinotropic hormone and glucose concentrations - Nauck, MA; Bartels, E; Orskov, C (J Clin Endocrinol Metab, 1993)
et al.